Pharmacy Times speaks with Helen Latimer, MPH, to discuss the advancement of HRR genetic testing equity in metastatic prostate cancer.
Helen Latimer, MPH
Advertisement
Articles by Helen Latimer, MPH
Pharmacy Times interviews Helen Latimer, MPH, about new real-world data examining racial disparities and evolving trends in HRR genetic testing among patients with metastatic prostate cancer and the implications for equitable access to precision oncology care.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on Pharmacy Times
1
New Hypertension Guideline: Key Shifts for Pharmacists
2
Trastuzumab Deruxtecan Superior to Chemoimmunotherapy in HER2-Mutant Advanced NSCLC
3
Osimertinib, Savolitinib Improve PFS and OS in MET-Driven EGFR-Mutated NSCLC
4
Family-Based Obesity Treatment Works in Primary Care
5